196 results
Page 2 of 10
424B5
iy619
24 Mar 21
Prospectus supplement for primary offering
5:14pm
424B5
sn3yg 2olfcvp8u
22 Mar 21
Prospectus supplement for primary offering
4:39pm
8-K
EX-99.1
st2g 7x1sgf9
16 Nov 20
Windtree Therapeutics Reports Third Quarter 2020
7:40am
8-K
EX-99.1
mxjivjdd ls5x2eg
1 Oct 20
Windtree Announces First Patient Dosed in Phase 2 Study of Istaroxime for the Acute Treatment of Early Cardiogenic Shock in Heart Failure Patients
7:36am
8-K
EX-10.1
0yt6o sdq
23 Jul 20
Departure of Directors or Certain Officers
4:55pm
424B4
2o12rued
21 May 20
Prospectus supplement with pricing info
6:04am
S-1/A
43mb1cdqtla
6 May 20
IPO registration (amended)
5:31pm